e-learning
resources
Vienna 2009
Sunday, 13.09.2009
FeNO and other biomarkers in childhood asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Iron concentrations in exhaled breath condensate of children with asthma and gastroesophageal reflux disease
Z. Vlasic, S. Dodig, I. Cepelak, R. Zrinski Topic, B. Nogalo, M. Turkalj, D. Plavec (Zagreb, Croatia)
Source:
Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Session:
FeNO and other biomarkers in childhood asthma
Session type:
Thematic Poster Session
Number:
1205
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Vlasic, S. Dodig, I. Cepelak, R. Zrinski Topic, B. Nogalo, M. Turkalj, D. Plavec (Zagreb, Croatia). Iron concentrations in exhaled breath condensate of children with asthma and gastroesophageal reflux disease. Eur Respir J 2009; 34: Suppl. 53, 1205
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Assessment of exhaled breath condensate for non-invasive diagnosis of gastroesophageal reflux disease
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
Identification of laryngopharyngeal reflux and acid aspiration using exhaled breath condensate pH
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005
Exhaled breath condensate pH for the identification of asymptomatic children at risk of asthma
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 269-274
Year: 2005
The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Leukotrienes and 8-isoprostane in exhaled breath condensate of children with asymptomatic steroid-naive asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002
Leukotrienes in exhaled breath condensate of children with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001
Inflammatory markers in exhaled breath condensate differ between pre-school children with and without recurrent wheeze
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Detection of pepsin in sputum and exhaled breath condensate: could it be a useful marker for reflux-related respiratory disease?
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Copper and zinc in exhaled breath condensate of emphysema patients
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
Zinc and magnesium in serum and exhaled breath condensate of patients with obstructive lung diseases and healthy controls
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Nitrite levels in breath condensate of children with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001
Metabonomics applied to exhaled breath condensate in childhood asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 123s
Year: 2006
Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept